WO2008123266A1
|
|
Target protein and target gene for drug discovery, and screening method
|
WO2008114709A1
|
|
Biomarker specific to blood cell or specific to osteoclast differentiation
|
WO2008111634A1
|
|
Biomarker specific to brain/nerve or specific to neuronal differentiation
|
WO2008114672A1
|
|
Cancer-specific biomarker
|
WO2008102912A1
|
|
Target protein and target gene for drug discovery, and screening method
|
JP2008174495A
|
|
Target protein and target gene for use in drug development and method for screening the same
|
WO2007026969A1
|
|
Drug target protein and target gene, and screening method
|
US2010094026A1
|
|
Method of screening compound useful in treating allergic disease
|
WO2006101272A1
|
|
Target protein and target gene for drug discovery and screening method
|
WO2006080559A1
|
|
Method for effective search for target molecule
|
WO2006052000A1
|
|
Target protein and target gene in drug designing and screening method
|
WO2006043710A1
|
|
Drug development target protein and target gene, and method of screening
|
WO2006043691A1
|
|
Target protein and target gene in drug designing and screening method
|
WO2006011673A1
|
|
Solid support having ligand immobilized thereon by using photocleavable linker
|
WO2005115468A1
|
|
Novel drug discovery target and medicine acting on the same
|
WO2005054216A1
|
|
Novel anticancer agent “sulcoxin”
|
EP1690852A1
|
|
Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto
|
WO2005054468A1
|
|
Target protein of antidiabetic agent and novel antidiabetic agent “insuful” corresponding thereto
|
US2007122913A1
|
|
Method of calibrating ligand specificity
|
EP2110393A1
|
|
Affinity resin
|